An open-label trial in 2050 elderly outpatients with depression treated with escitalopram in a naturalistic setting in Germany

被引：0
|
作者：
Moeller, H.-J. [1 ]
Schnitker, J. [2 ]
Fluerenbrock, W. [3 ]
Fuger, J. [4 ]
机构：
[1] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[2] Inst Angew Stat GmbH, Bielefeld, Germany
[3] Lundbeck GmbH, Sci Unit, Hamburg, Germany
[4] Lundbeck GmbH, Med Affairs, Hamburg, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [41] An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients
    Mehmet A. Ersoy
    Aysin M. Noyan
    Hayriye Elbi
    Clinical Drug Investigation, 2008, 28 : 113 - 120
  • [42] Bupropion-SR for Smoking Reduction and Cessation in Alcohol-Dependent Outpatients: A Naturalistic, Open-Label Study
    Karam-Hage, Maher
    Robinson, Jason D.
    Lodhi, Ashutosh
    Brower, Kirk J.
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (02): : 123 - 129
  • [43] A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression
    Siwek, Marcin
    Chrobak, Adrian Andrzej
    Soltys, Zbigniew
    Dudek, Dominika
    Krupa, Anna Julia
    Rybakowski, Janusz Kazimierz
    PSYCHIATRIA POLSKA, 2022, 56 (03) : 509 - 522
  • [44] A Randomized Open-label Study to Evaluate the Effects of Escitalopram and Mirtazapine on Psychomotor Functions and Memory in Patients with Depression
    Modi, Anal
    Desai, Mira
    Shah, Samidh
    Parikh, Minaxi
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2018, 9 (04) : 174 - 179
  • [45] Lidocaine 5% patch: An open-label naturalistic chronic pain treatment trial and prediction of response
    Fishbain, DA
    Lewis, JE
    Cole, B
    Cutler, B
    Rosomoff, HL
    Rosomoff, RS
    PAIN MEDICINE, 2006, 7 (02) : 135 - 142
  • [46] Quality of Life in 833 outpatients with major depression treated with open-label venlafaxine extended release: An observational 24-week study
    Cervera-Enguiz, S
    Soutullo, CA
    Landecho, I
    Murillo-Jelsbak, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 193 - 197
  • [47] Switching forensic schizophrenia outpatients from long-acting injectable antipsychotics to olanzapine: An open-label naturalistic study
    Bourget, D
    Labelle, A
    Boulay, LJ
    Tessier, P
    Ellis, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 160 - 161
  • [48] Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
    Wilkowska, Alina
    Wlodarczyk, Adam
    Galuszko-Wegielnik, Maria
    Wiglusz, Mariusz S.
    Cubala, Wieslaw J.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2637 - 2646
  • [49] An open-label naturalistic study: Mirtazapine orally disintegrating tablets treatment for depression in heroin-addicts
    Shao, C.
    Zhu, S.
    Wang, Z.
    Shi, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 128 - 129
  • [50] Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial
    Cornelius, JR
    Bukstein, OG
    Birmaher, B
    Salloum, IM
    Lynch, K
    Pollock, NK
    Gershon, S
    Clark, D
    ADDICTIVE BEHAVIORS, 2001, 26 (05) : 735 - 739
12345